Novartis on Thursday reports a 19% second-quarter profit rise and hikes its sales outlook for the year as the pharmaceutical benefited from growing cancer and cardiovascular drug sales as well as its arm that makes copycat medications.
MarketWatch.com - Top Stories, MarketWatch
Thu, 07/15/2010 - 1:32am